Biosimulation Technology Market Size, Application Report

Biosimulation Technology Market Size, Application Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2014 To 2020

Format: PDF  |  Report ID: GVR1329

Biosimulation technology market is expected to grow at a lucrative rate over the forecast period owing to the increasing use of pharmacokinetic and pharmacodynamic (PKPD) method during preclinical drug development process. The other drivers of this market are increasing expenditure on healthcare, time and cost spent on drug development and discovery, failure of drugs during development stages, less production of output, upgraded modeling and simulation tools, and growing importance of advanced technologies. Manufacturers are now focusing on the biosimulation technology to reduce the wastages during the drug development stage. Pharmacokinetics process describes the drugs course concentration-time, with help of body fluids.

Biosimulation technology market is segmented on the basis of application into drug development and drug discovery. Drug development is further divided into preclinical testing, clinical trials and patient validation. Among these pre-clinical testing holds the lager market share. This stages deals with all the researches which are done before clinical trials phase. These details are further used in next process. The main purpose of this phase is to produce safe dose for the human beings, without any flaws.  Drug discovery is further segmented into lead identification, target identification, lead optimization and target validation. Among these,  target identification holds the larger market share. Protein structure prediction is the 3D structure of protein, which is extracted from amino acid sequence of the drugs.

North America is dominating the market followed by Europe, due to the presence of strong research and development, increasing advanced technologies and various government initiatives and programs along with presence of huge numbers of manufactures. Most of the domestic and international players are focusing on the emerging market, such as China and India, as these are lucrative market and are expected to grow in the biosimulation technology market.

The major market players of biosimulation technology market are Accelyrs, Inc., Chemical Computing Group, Molecular Knowledge Systems, Inc., Rhenovia Pharma S.A.S, Simulations Plus, Inc., Certara, Simulations Plus, Inc., Advanced Chemistry Development (Acd/Labs), and Insilico Biotechnology Ag.

Key questions answered by the report
Request for Customization

Choose License Type:

Single User - $4,950
Multi User - $7,950
Enterprise User - $9,950

Special Pricing & Discounts

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA